Guidance
Bisphosphonates: use and safety
Guidance on the use and safety of bisphosphonates for bone-related conditions.
Documents
Details
This Medicines and Healthcare Products Regulatory Agency (MHRA) guidance for healthcare professionals covers:
- oesophageal reactions
- osteonecrosis of the jaw
- atrial fibrillation
- atypical femoral fractures
- adverse effects on renal function
Updates to this page
Published 18 December 2014